HUL-GSK Consumer deal is a win-win for shareholders, say analysts

The deal, which is expected to be completed in 12 months, will see the HUL's turnover of foods & refreshments business exceed Rs 100 billion.

Shares of Hindustan Unilever (HUL) and GSK Consumer Healthcare climbed 4.7 per cent to Rs 1,836 levels and 4.1 per cent to Rs 7,565 levels respectively, after their respective boards approved their merger, subject to obtaining requisite approvals from statutory authorities and shareholders.

Unilever on Monday confirmed it was acquiring Horlicks and other health food products in an all-equity merger of Hindustan Unilever Ltd (HUL) with publicly listed GSK Consumer Healthcare India.
 

The merger of HUL with GSK Consumer Health will be on the basis of an exchange ratio of 4.39 HUL shares for each GSK Consumer Health share. The